Executive Vice President and CEO - Digital Bart Schaller of Synchrony Financial (NYSE:SYF) carried out a planned sale of company stock and concurrently had a block of restricted stock units vest in early March 2026, according to a regulatory filing.
On March 2, 2026, Schaller sold 12,980 shares of Synchrony common stock at a price of $67.71 per share, resulting in proceeds of $878875. That disposition was made pursuant to a Rule 10b5-1 trading plan that Schaller adopted on October 29, 2025, the Form 4 filing shows.
Separately, the filing indicates Schaller acquired 14,610 shares of Synchrony common stock on March 1, 2026. Those shares reflect restricted stock units that vested and were valued at $69.11 apiece, amounting to a total value of $1009697. The RSUs vest in three equal annual installments, beginning on the first anniversary of the grant date, with each unit representing a contingent right to receive one share of Synchrony Financial common stock.
Also on the vesting date, Synchrony withheld 9,895 shares to cover the tax liability tied to the RSU vesting. Those withheld shares were valued at $69.11 each, for a cumulative value of $683843. After accounting for the sale, the newly vested units and the tax withholding, Schaller's direct ownership stands at 34,035 shares of Synchrony Financial common stock.
Valuation context and investor signals
The insider activity occurred while Synchrony Financial is trading at a price-to-earnings ratio of 7.47 and is quoted near InvestingPro's Fair Value estimate, which the InvestingPro note interprets as the shares potentially being slightly undervalued. An InvestingPro tip included in the filing materials highlights that the company delivers a high shareholder yield, and cites a $23.87 billion market capitalization combined with consistent dividend growth as supporting factors. InvestingPro also offers a Pro Research Report covering this company and more than 1,400 other U.S. equities for readers seeking deeper valuation and performance analysis.
Recent company performance and strategic partnerships
Synchrony announced fourth-quarter 2025 results that showed net earnings of $751 million, or $2.04 per diluted share, matching analyst expectations for earnings per share. Revenue for the quarter totaled $3.79 billion, however, which missed the anticipated $3.84 billion figure.
On the strategic front, Synchrony expanded its partnership with Planet DDS to integrate the CareCredit financing solution across dental practice management platforms, including Denticon and Cloud 9. The company noted this multi-year arrangement marks Synchrony’s first integration into an orthodontic-specific practice management system. Synchrony also entered a partnership with Weave to bring CareCredit patient financing into Weave’s platform for healthcare businesses.
Analyst commentary
In a recent update, Baird raised its rating on Synchrony Financial from Neutral to Outperform, pointing to solid pre-provision net revenue trends and favorable credit metrics. Baird set a price target of $83.00 and framed recent weakness in consumer finance stocks as a potential buying opportunity for investors.
All transactions and metrics reported above are drawn from the company's regulatory filing and published company results. The Form 4 documents the insider transactions and the company disclosures detail earnings, partnerships and analyst action as noted.